1 [3 (2,4 dichlorophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (2,4 dichlorophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 bromophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 bromophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 chlorophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 chlorophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)py [1] |
1 acetyl 3,5 diaryl 4,5 dihydro(1h)pyrazole derivative [1] |
1 aryl 2 (1h imidazol 1 yl)methyl) 6 substituted 1h indole [1] |
1 bromo 3 chloro 5,5 dimethylhydantoin [1] |
1 methoxycanthinone [1] |
1,2,4 triazole derivative [1] |
1,3,4-oxadiazoles [1] |
1,4-Dihydropyrazolo[4,3-b]indoles [1] |
10 hydroxycamptothecin [1] |
13-Diaryl propenones [1] |
17?-hydroxysteroid dehydrogenase type 5 inhibitors [1] |
17β-hydroxysteroid dehydrogenase [1] |
2 (1 acetyl 1h indol 3 yl) 3 (4 (dimethylamino)phenyl)acrylic acid [1] |
2 (2 chloro 4 iodoanilino) n cyclopropylmethoxy 3,4 difluorobenzamide [1] |
2 (2 fluoro 4 iodoanilino) 1,6 dihydro n (2 hydroxyethoxy) 1,5 dimethyl 6 oxonicotinamide [1] |
2 amino 4 (1 benzyl 1h indol 2 yl) 5 oxo 5,6,7,8 tetrahydro 4h chromene 3 carbonitrile [1] |
2 amino 4 (1 benzyl 1h indol 2 yl) 5 oxo 7 phenyl 5,6,7,8 tetrahydro 4h chromene 3 carbonitrile [1] |
2 amino 4 (1 benzyl 1h indol 2 yl) 7 methyl 5 oxo 5,6,7,8 tetrahydro 4h chromene 3 carbonitrile [1] |
2 amino 4 (1 benzyl 1h indol 2 yl) 7,7 dimethyl 5 oxo 5,6,7,8 tetrahydro 4h chromene 3 carbonitrile [1] |
2 amino 4 (1 benzyl 1h indol 2 yl) 8,8 dimethyl 5 oxo 5,6,7,8 tetrahydro 4h chromene 3 carbonitrile [1] |
2 amino 7 (benzo [1] |
2 methoxy 4 (2 phenyl 5,6 dihydropyrazolo[1,5 c]quinazolin 5 yl)phenol [1] |
2 methoxy 5 (2 phenyl 5,6 dihydropyrazolo[1,5 c]quinazolin 5 yl)phenol [1] |
2 methyl 4 (4 tolyl) 6 (3,4,5 trimethoxyphenyl)pyrimidine [1] |
2 methyl 4 phenyl 6 (3,4,5 trimethoxyphenyl)pyrimidine [1] |
2 methyl 4,6 diphenylpyrimidine [1] |
2 phenyl 5,6 dihydropyrazolo[1,5 c]quinazoline 5 carboxylic acid [1] |
2,4-Diaminoquinolines [1] |
2,4-thiazolidinedione, 2-thioxo-4-thiazolidinone [1] |
2-(2-Arylphenyl)benzoxazoles; 3D QSAR; cyclooxygenase-2 selective; in vivo potency; novel anti-inflammatory scaffold [1] |
2-amino-spiro-pyrans [1] |
2-Arylimidazo[1,2-a]pyridinyl-3-amines [1] |
2-minothiophenes [1] |
2-pyrazolines [1] |
2-thioxo-thiazolidin-4-one [1] |
25 Hydroxyvitamin D [1] |
2D QSAR [1] |
2D-QSAR docking model [1] |
3 (2,3 dihydroxypropyl) 6 fluoro 5 (2 fluoro 4 iodoanilino) 8 methylpyrido[2,3 d]pyrimidine 4,7 dione [1] |
3 indolemethanol [1] |
3 methoxymethyl [1] |
3,4 difluoro 2 (2 fluoro 4 iodoanilino) n (2 hydroxyethoxy) 5 [(3 oxo 1,2 oxazinan 2 yl)methyl]benzamide [1] |
3,5 dihydroimidazo [1,2] pyrimidine [1] |
3-d]pyrimidines [1] |
3D Culture [1] |
3D QSAR [1] |
3D-QSAR [5] |
3h pyrazolo[4,3] pyrimidine [1] |
4 (2 phenyl 5,6 dihydropyrazolo[1,5 c]quinazolin 5 yl)benzonitrile [1] |
4 (2 phenyl 5,6 dihydropyrazolo[1,5 c]quinazolin 5 yl)phenol [1] |
4 (2,4 dichlorophenyl) 6 (3,4,5 trimethoxyphenyl)pyrimidin 2 amine [1] |
4 (3,4 dimethoxyphenyl) 2 methyl 6 (4 tolyl)pyrimidine [1] |
4 (3,4 dimethoxyphenyl) 2 methyl 6 phenylpyrimidine [1] |
4 (3,4 dimethoxyphenyl) 6 (4 methoxyphenyl) 2 methylpyrimidine [1] |
4 (4 chlorophenyl) 2 methyl 6 (3,4,5 trimethoxyphenyl)pyrimidine [1] |
4 (4 chlorophenyl) 6 (3,4 dimethoxyphenyl)pyr [1] |
4 [2 (2 chlorophenyl) 5,6 dihydropyrazolo[1,5 c]quinazolin 5 yl)phenol [1] |
4 hydroxyestradiol [1] |
4 nitrophenylenediamine [1] |
4,5 dihydro 1h pyrazole [1] |
4-Phenyl-1,2,3-triazolepyrimidines [1] |
4-thiazolidinones [2] |
5 (2 chlorobenzylideneamino) 1 benzyl 6,7 dihydro 6 (2 chlorophenyl) 1h pyrazolo[3,4 d]pyrimidin 4 (5h)one [1] |
5 (3 methoxy 4 hydroxybenzylideneamino) 1 benzyl 1h pyrazolo[3,4 d]pyrimidin 4 (5h)one [1] |
5 (4 methoxybenzylideneamino) 1 benzyl 6,7 dihydro 6 (4 methoxyphenyl) 1h pyrazolo[3,4 d]pyrimidin 4 (5h)one [1] |
5 benzylated 4 oxo 3, 4 dihydro 5h pyridazino(4,5 b)indole [1] |
5 ureidobenzofuranone indole [1] |
5,6-Dihydropyrazolo/pyrazolo[1,5-c]quinazoline [1] |
5,7 dihydrofuro [3,4] pyrimidine [1] |
5,7 dihydrothieno [3,4] pyrimidine [1] |
5-Fluorouracil [1] |
5-FU [1] |
5h pyrano[4,3] pyrimidine [1] |
5h thiazolo [3,2] pyrimidine [1] |
5h thiopyrano [4,3] pyrimidine [1] |
6 methoxy 2 methyl 3 (3,4,5 trimethoxybenzoyl)benzofuran 7 yl phosphate disodium [1] |
6,7 dihydro 5h pyrrolo 2,3] pyrimidine [1] |
6-Amino-uracil [1] |
6h pyrano [3,2] pyrimidine [1] |
7 methoxy 2 (1h pyrrol 2 yl) 3 ((3,4,5 trimethoxyphenyl)thio 1h indole [1] |
7,8 dihydropteridine [1] |
7h pyrrolo [3,2] pyrimidine [1] |
8,9 dihydro 7h purine [1] |
9h purine [1] |
?-amylase [1] |
?-cyclodextrin [1] |
?-Synuclein [1] |
?C-helix [1] |
A/S [1] |
Abelson kinase [2] |
Academia [1] |
acetylcholine esterase [1] |
Acetylcholinesterase inhibitors [2] |
acetylcholinesterase inhibitors [1] |
acne [1] |
Activin receptor like kinase 1 [1] |
Activities [1] |
adenocarcinoma [1] |
adenosine deaminase [1] |
adenosine deaminase inhibitor [1] |
adenosine triphosphate [1] |
ADME [4] |
ADMET and physicochemical properties [1] |
ADMET prediction [1] |
ADR [1] |
Adult [1] |
advanced cancer [1] |
adverse drug reactions [1] |
Aedes [1] |
Affinity [1] |
Aged [1] |
agents acting on the genital system [1] |
agents acting on the peripheral nervous and neuromuscular systems [1] |
agents affecting metabolism [1] |
Aggregation Property [1] |
Agroclavine [1] |
AIDS [3] |
air pollution [1] |
Alcuronium [1] |
Aldehyde Dehydrogenase [1] |
Aldehyde reductase (ALR1) [1] |
ALDH1A1*1/*2 [1] |
Aldose reductase [1] |
Aldose reductase (ALR2) [1] |
Alkaloid Derivative [1] |
Alkaloid derivative [1] |
Alkaloids [3] |
alkaloids [1] |
Alkyl Aryl Ether [1] |
Alkylglycerophosphoethanolamine Phosphodiesterase [1] |
allopurinol [1] |
Allosteric modulators [1] |
Allosteric Regulation [2] |
Allosteric Site [1] |
allosteric site [1] |
Allosterism [2] |
allosterism [1] |
Allosterism Binding Site [1] |
Allostery [1] |
alpha amino 5 tert butyl 3 hydroxy 4 isoxazolepropionic acid [1] |
Alpha Glucosidase Inhibitor [1] |
alpha helix [1] |
Alpidem [1] |
Alzheimer Disease [1] |
Alzheimer's disease [2] |
Alzheimer’s disease [1] |
Alzheimer�s Disease [1] |
Ambiguine h isonitrile [1] |
Ames test [1] |
amide [2] |
Amine Oxidase (Flavin Containing) [1] |
Amineptine [1] |
Amino Acid [1] |
Amino acid [1] |
Amino acid catalysis [1] |
Amino Acid Sequence [1] |
Amino Acids [1] |
Amino acids [1] |
Aminophenazone [1] |
Amodiaquine [1] |
Amyloid ? [1] |
Analgesic activity [1] |
Analgesics [1] |
analytical [1] |
Analytical developments [1] |
anaplastic lymphoma kinase [1] |
and cell lines [1] |
and simulations [1] |
anetumab ravtansine [1] |
Angiogenesis Carcinogenesis [1] |
Animal [3] |
Animal Cell [1] |
Animal Cell Culture [1] |
Animals [3] |
Antagonist [1] |
Antagonists [1] |
anthelmintics [1] |
Anthraquinones [1] |
anthraquinones [1] |
Anti-apoptosis [1] |
Anti-Bacterial Agents [1] |
Anti-cancer [1] |
anti-cancer [2] |
Anti-cancer agents [2] |
Anti-cancerous drugs [1] |
Anti-epileptic [1] |
Anti-estrogenic [1] |
Anti-inflammatory [2] |
Anti-mutagenic [1] |
Anti-retroviral agents [2] |
anti-tubercular agents [1] |
anti-tubulin [1] |
Anti-tumors [1] |
antibacterial [3] |
Antibacterial activity [4] |
antibacterial activity [2] |
Antibacterial agents [1] |
Antibacterial Resistance [1] |
Antibacterials [1] |
Antibiotics [1] |
Antibiotics, Antineoplastic [1] |
Antibodies, Monoclonal [1] |
antibody drug conjugate [2] |
Anticancer [16] |
anticancer [5] |
Anticancer Activity [1] |
Anticancer activity [2] |
Anticancer agents [2] |
anticancer agents [1] |
Anticancer Mechanisms [1] |
anticancer potential [1] |
Anticonvulsant activity [1] |
antidepressants [1] |
antidiabetic [1] |
Antidiabetic activity [1] |
Antidiabetic Activity Binding Affinity [1] |
antifungal [1] |
Antifungal activity [3] |
Antifungal Agent [1] |
Antifungal Agents [1] |
Antiglycation [1] |
Antiinfective Agent [1] |
antiinfective agent [1] |
antimalarial agent [1] |
Antimalarials [1] |
Antimicrobial [4] |
antimicrobial [2] |
antimicrobial activity [1] |
Antimicrobial resistance [1] |
Antimicrobials [1] |
Antimutagenic [1] |
Antimutagenic activity [1] |
Antimutagenic agent [2] |
Antineoplastic Activity [1] |
Antineoplastic activity [1] |
antineoplastic activity [1] |
antineoplastic activity cancer patient [1] |
Antineoplastic Agent [3] |
Antineoplastic agent [2] |
antineoplastic agent [3] |
Antineoplastic Agents [1] |
Antineoplastic Agents, Phytogenic [1] |
Antineoplastic Metal Complex [1] |
Antinociceptive [2] |
Antioxidant [4] |
Antioxidant activity [2] |
antioxidant activity [2] |
Antioxidant property [1] |
Antiproliferative [4] |
Antiproliferative activity [1] |
Antiproliferative; [1] |
Antipyretic activities [1] |
antisense oligonucleotide [1] |
Antitumor agents [1] |
antiviral [1] |
Antiviral agents [1] |
Anxiety [1] |
AP-sites [1] |
APE1 [1] |
Apirimidinic Endonuclease 1 [1] |
Apoptosis [2] |
apoptosis [2] |
Aqueous medium [1] |
Aqueous Solution [1] |
Arginase [1] |
Aromatase [5] |
aromatase inhibitor [1] |
Aromatase inhibitors [6] |
Aromatic compounds [2] |
aromatic hydrocarbon [1] |
Artemisia [1] |
Artemisia Ketone [1] |
Artemisia maritima [1] |
Artemisia nilagirica [1] |
Article [2] |
Aryl aldehydes [1] |
arylation [1] |
arylthiazole [1] |
arylthioindole [1] |
Ashwagandha [1] |
Asparagus racemosus [4] |
Asparagus racemosus extract [1] |
Asteraceae [1] |
atezolizumab [1] |
Atropisomerism [1] |
Atropisomers [1] |
Aurovertin [1] |
autoimmune disease [1] |
Autophagy [1] |
Autotaxin [1] |
avutometinib [1] |
Ayurvedic drug [1] |
azaindole [1] |
Backbone modification [1] |
Bacteria [1] |
bacteria [1] |
Bacterial mutation [1] |
Bacterial strain [1] |
Bacteriophage [1] |
Base catalysis [1] |
BC [1] |
BCL-2 [1] |
BCL-XL [1] |
Bedaquiline [1] |
Benoxaprofen [1] |
Benzimidazole [1] |
Benziodarone [1] |
benzonitrile [1] |
Benzothiazole [1] |
BER Pathway [1] |
berberine [1] |
bi 847325 [1] |
Biaryl linkage [1] |
Biased agonism [1] |
Biginelli reaction [1] |
binding affinity [1] |
Binding energy study [1] |
binimetinib [1] |
Bioaccumulation [1] |
Bioactive O-heterocycles [1] |
Bioavailability [2] |
bioavailability [1] |
biocatalysts [1] |
Biochemical Composition [1] |
Biocompatibility [1] |
biofilms [1] |
biologic factors and agents acting on the immune system [1] |
Biological Activities [1] |
Biological activity [1] |
biological activity [3] |
biological efficacy [1] |
Biological Model [1] |
biological products [1] |
Biologics [1] |
biomarkers [1] |
Biopesticides [1] |
Biphenyl [1] |
Biphenyl analogues [1] |
bisindolylalkane [1] |
Bithionol [1] |
Biting deterrence [1] |
Biting deterrent [1] |
Biting deterrent activity [3] |
Bladder tumor [1] |
block copolymer [1] |
Blood [1] |
blood cancer [1] |
Bms 577098 [1] |
Boron [1] |
boron [1] |
Boron neutron capture therapy [1] |
BRAF [1] |
BRCA1 gene [1] |
breakpoint cluster region protein [1] |
Breast Cancer [3] |
Breast cancer [18] |
breast cancer [2] |
BRG1 protein [1] |
BRM protein [1] |
Broad spectrum [1] |
Bromfenac [1] |
Bromocriptine [1] |
Bruton tyrosine kinase [1] |
Butanol [1] |
bya 869766 [1] |
C-4 substituted coumarin [1] |
C[sbnd]N bond formation [1] |
CA-MRSA [1] |
Cadogan Cyclization [1] |
Cadogan cyclization [1] |
Cadogan/cadogan-sundberg reaction [1] |
Camphor [1] |
camptothecin [1] |
Canc [1] |
Cancer [19] |
cancer [2] |
Cancer Cell [1] |
Cancer Chemotherapy [1] |
cancer chemotherapy [2] |
Cancer Patient [1] |
Cancer Resistance [3] |
cancer resistance [1] |
Cancer Stem Cell [3] |
Cancer stem cell [1] |
Cancer stem cells [1] |
cancer therapy [1] |
Cannabinoid [1] |
Carbazole [2] |
carbazole [1] |
Carbohydrates [1] |
carboline [1] |
Carbon [1] |
Carbon Nanotube [1] |
Carbon nanotube [1] |
Carbon Nanotubes [1] |
carcinogenic activity [1] |
cardiovascular agent [1] |
cardiovascular disease [1] |
carrier protein [1] |
Carrier Proteins [1] |
Case Control Study [1] |
Cassia fistula [2] |
Catalysis [1] |
Catalyst free novel methodology [1] |
Catalytic Domain [1] |
catalytic loop [1] |
Caucasian [1] |
Causes of death [1] |
Cd133 Antigen [1] |
CD135 antigen [1] |
Cd24 Antigen [1] |
Cd34 Antigen [1] |
Cd38 Antigen [1] |
Cell Assay [1] |
Cell culture [1] |
Cell cycle arrest [1] |
Cell Cycle G0 Phase [1] |
Cell Cycle Progression [1] |
Cell cycle progression [1] |
Cell Cycle Regulation [1] |
Cell Death [1] |
Cell Line [1] |
Cell Line, Tumor [1] |
cell lines [1] |
Cell Marker [1] |
Cell Migration [2] |
cell migration [1] |
Cell Population [1] |
cell signaling assay [1] |
Cell Stress [1] |
Cell Survival [3] |
Cell Via [1] |
Cells [1] |
cellular target [1] |
central nervous system agents [1] |
chaperones [1] |
Characterization [1] |
Chemical activation [1] |
Chemical analysis [1] |
Chemical biology [1] |
Chemical Bond [1] |
Chemical space [1] |
Chemical stability [1] |
Chemical Structure [2] |
Chemistry [6] |
chemistry [1] |
Chemistry, Pharmaceutical [1] |
Chemoresistance [1] |
chemoresistance [1] |
Chemotherapy [5] |
Chiral drug development [1] |
Chitosan [2] |
Chlormezanone [1] |
Chloroquine [1] |
Cholesterol [1] |
chorioretinopathy [1] |
Chromatography, High Pressure Liquid [1] |
Chromene [3] |
Chromotographic Techniques [1] |
Chronic constriction injury [1] |
Chronic fatigue syndrome [1] |
Cineole [1] |
circulating nucleic acids [1] |
Citrullus colocynthis [1] |
Classification [1] |
Clinical outcome [1] |
Clinical reports [1] |
Clinical trial [1] |
Clinical Trial (Topic) [1] |
Clinical Trials As Topic [1] |
CNS disorders [1] |
cobimetinib [1] |
coformycin [1] |
Cognition [1] |
colchicine [1] |
Colchicine binding site [1] |
Collagen [1] |
collagen remodeling [1] |
colon cancer [1] |
colon/colorectal cancer [1] |
Colorectal cancer [1] |
colorectal cancer [1] |
coltuximab ravtansine [1] |
Column chromatography [1] |
Combination of EOs and their constituents [1] |
Combination with antibiotics [1] |
combretastatin A1 phosphate [1] |
combretastatin A4 phosphate [1] |
CoMFA [1] |
Comparative Molecular Field Analysis [1] |
Computational chemistry [1] |
Computer Aided Design [1] |
Computer Model [1] |
Computer-Aided Design [1] |
CoMSIA [1] |
Con [1] |
Confocal Microscopy [2] |
Conformation [1] |
conformations [1] |
Conjugates [1] |
Controlled Study [4] |
Controlled study [1] |
Copper [1] |
corticotropin releasing factor [1] |
Corynan [1] |
Corynantheine [1] |
Coumarin [4] |
coumarin [1] |
COVID-19 [3] |
Covid-19 [3] |
COVID-19 diagnosis [1] |
Crosstalk [1] |
Crosstalk, [1] |
cryptic species [1] |
Cryptolepine [1] |
crystal structure [1] |
Crystallography, X-Ray [1] |
Cucumis melo var. agrestis Naudin [1] |
Curcumin [1] |
Cyanoquinoline [1] |
Cyclic enaminone [1] |
Cyclin Dependent Kinase [1] |
cyclin dependent kinase 9 [1] |
Cyclocondensation [2] |
Cyclohexanol Derivative [1] |
Cyclohexanols [1] |
cytochrome P4 [1] |
Cytokine Production [1] |
Cytoplasm [1] |
cytotoxic agent [1] |
Cytotoxicity [2] |
cytotoxicity [1] |
D-alanine: D-alanine Ligase Drug discovery [1] |
D-Mannose conjugated nanoparticles [1] |
dabrafenib [1] |
dacarbazine [1] |
Damnacanthal [1] |
De novo designing [1] |
Dearomatization [1] |
Decarboxylation [1] |
depression [1] |
dermatitis [1] |
dermatological agent [1] |
design [1] |
Detection limit [1] |
deuterium [1] |
DFG [1] |
DFG motif [1] |
DFT study [1] |
DHFR [1] |
DHPS [1] |
Diabesity [1] |
Diabetes [1] |
Diabetes mellitus [3] |
diabetes mellitus [2] |
Diabetes Mellitus, Type 2 [1] |
Diabetic complications [2] |
Diagnosis [1] |
Diagnostic [1] |
diagnostic agent [1] |
Diagnostic applications [1] |
diarrhea [1] |
Dicotyledon [1] |
differentiated thyroid cancer [1] |
dihydropyrazolo[1,5 c]quinazoline derivative [1] |
Dihydropyridine [1] |
Dihydropyrimidinone [1] |
Dihydropyrimidinones [1] |
dimedone [1] |
dimer [1] |
dimerization [1] |
Dimers [1] |
Dipeptidyl Peptidase Iv Inhibitor [1] |
dipeptidyl peptidase-4 [1] |
Diphenylpyrimidine [2] |
diphenylpyrimidine [1] |
Dipyrone [1] |
Disease outcome [1] |
Diseases [1] |
Dispersion (Waves) [1] |
Dispersions [1] |
Dissolution [1] |
distribution [1] |
Diterpenes, Kaurane [2] |
DNA [1] |
Dna (Apurinic Or Apyrimidinic Site) Lyase [1] |
Dna Damage [1] |
DNA Repair [1] |
Dna Repair [1] |
DNA topoisomerase [2] |
DNA topoisomerase (ATP hy [1] |
DNA topoisomerase (ATP hydrolysing) [1] |
DNA topoisomerase inhibitor [2] |
docetaxel [1] |
Docking [4] |
docking [3] |
docking and simulation [1] |
Docking scores [1] |
Docking studies [1] |
Docking study [1] |
double emulsion [1] |
Doxorubicin [2] |
dps 2 [1] |
Dracocephalum heterophyllum [2] |
Drug [2] |
Drug activity [2] |
Drug Approval [1] |
drug approval [1] |
Drug Binding Site [1] |
drug binding site [1] |
Drug Cytotoxicity [1] |
Drug delivery [1] |
drug delivery [1] |
Drug Delivery System [2] |
Drug Design [2] |
Drug design [1] |
drug design [4] |
Drug Development [2] |
Drug development [3] |
drug development [1] |
Drug Discovery [1] |
Drug discovery [2] |
Drug Effects [1] |
drug efficacy [1] |
drug identification [1] |
drug indication [1] |
drug interaction [1] |
Drug isolation [1] |
Drug Mechanism [1] |
drug mechanism [1] |
drug metabolism [1] |
drug metabolizing enzyme [1] |
Drug Potentiation [1] |
Drug products [1] |
drug receptor binding [1] |
Drug Release [1] |
Drug repurposing [1] |
Drug Research [1] |
Drug Resistance [1] |
Drug resistance [1] |
Drug Screening [1] |
Drug screening [1] |
drug screening [1] |
drug selectivity [1] |
drug structure [1] |
Drug Synthesis [1] |
drug synthesis [1] |
Drug Targeting [1] |
drug targeting [2] |
Drug Targets [1] |
Drug toxicity [1] |
Drug use [1] |
Druggable targets [1] |
Drymaritin [1] |
Dual inhibitors [4] |
dual inhibitors [1] |
Dual/multi inhibitor [1] |
Dynamic axial chirality [1] |
Dynamics simulation [1] |
E Ha219 [1] |
e-LEA3D [1] |
E-pharmacophore [1] |
E. coli [1] |
ebi 1051 [1] |
Ebrotidine [1] |
ECM [1] |
Editorial [1] |
Efficacy [2] |
efficacy [1] |
EGFR [2] |
EGFR inhibitor [1] |
EGFR signaling [1] |
Elacestrant [2] |
electro-hydrodynamic atomization [1] |
electroformation [1] |
Electron Microscopy [1] |
Ellipticine [1] |
Embryo Development [1] |
Encapsulation [2] |
encapsulation [1] |
Encapsulation efficiency [1] |
encorafenib [1] |
Endocytosis [2] |
Endonuclease [1] |
environmental health [1] |
Enzyme [1] |
Enzyme Active Site [1] |
enzyme inhibitor [1] |
enzyme mechanism [1] |
Epidermal Growth Factor [1] |
Epidermal growth factor receptor [1] |
epidermal growth factor receptor [3] |
epidermal growth factor receptor 2 [1] |
epidermal growth factor receptor kinase inhibitor [1] |
epigenetic modifications [1] |
Epileptogenesis [1] |
Epithelial Cell Adhesion Molecule [1] |
equity [1] |
ER [2] |
ER-? [1] |
ER? [1] |
ErbB Receptors [1] |
Ergoline derivative [1] |
Erratum [1] |
error [1] |
Essential Oil [3] |
Essential oil [5] |
Essential oil, Antifungal activity [1] |
Essential Oils [1] |
Essential oils [2] |
Ester [1] |
Estradiol [1] |
Estrogen [5] |
estrogen [1] |
Estrogen receptor [4] |
Estrogen receptor (ER) [1] |
Estrogen receptor ? [1] |
Estrogen receptor alpha [1] |
estrogen receptor alpha [2] |
estrogen related receptor alpha [1] |
Eth [1] |
Ether Derivative [1] |
Etoposide [1] |
Eucalyptus tereticornis [1] |
Exposure [1] |
Extraction [2] |
extraction [1] |
fatigue [1] |
FDA [1] |
FDA approved Drugs [1] |
FDA approved drugs [1] |
FDA-approved drug [1] |
FDA-approved inhibitors [1] |
Fellutanine a [1] |
Fellutanine b [1] |
Female [1] |
Fenclofenac [1] |
Fenclozic Acid [1] |
fever [1] |
Field-based QSAR [1] |
firtecan [1] |
Fisetin [1] |
Five-membered ring fused pyrimidines [1] |
flavanone [1] |
Flavonoid [1] |
flavonoid [1] |
Flavonoids [5] |
flavonoids [2] |
Flow Cytometry [1] |
Fluorescent metal ion specimens [1] |
fluorine [1] |
Fluorophores [1] |
focal adhesion kinase [1] |
FoF1 ATP synthase inhibitor [1] |
Folate Receptor [1] |
Folate Receptors, Gpi-Anchored [1] |
Folic Acid [1] |
Food and Drug Administration [1] |
Food and nutrients [1] |
Forced swimming [1] |
Formulations [1] |
formulations [1] |
fractionation [1] |
Free Radical [1] |
Free Radicals [1] |
Free radicals [1] |
Free-radical scavenging [2] |
FTIR Spectroscopy [1] |
Fully functionalized pyridines [1] |
Fulvestrant [1] |
functional group [1] |
Functional polymers [1] |
Fungi [1] |
furo [3,2] pyrimidine [1] |
fused heterocyclic rings [1] |
Fused pyrimidine compounds [1] |
Fused pyrimidines [2] |
G Protein Coupled Receptor [2] |
Ganoderma lucidum [1] |
Gas Chromatography-Mass Spectrometry [1] |
gastrointestinal agent [1] |
Gastrointestinal and cardiovascular safety evaluation [1] |
gastrointestinal disease [1] |
Gaussian field [1] |
Gaussian field-based 3D QSAR [1] |
GC-MS analysis [1] |
GC-MS-FID [2] |
gdc 0623 [1] |
Ge [1] |
gel mobility shift assay; [1] |
geldanamycin [1] |
gemcitabine [1] |
Gene [1] |
Gene Expression [1] |
Gene Frequency [1] |
Gene Overexpression [1] |
Gene variants [1] |
Gene Variants, [1] |
Genetic Association [1] |
genetic disorder [1] |
genetic heterogeneity [1] |
Genetic Variability [1] |
Genetic Variation [1] |
Genetics [2] |
genetics [1] |
Geno [1] |
Genomic alterations [1] |
Genomic Alterations, [1] |
Genotype [1] |
Gewald Reaction [1] |
Glide docking [1] |
Glioblastoma [1] |
Global screening array [1] |
Glucan 1,3 Beta Glucosidase [1] |
Glucan 1,3-Beta-Glucosidase [1] |
glucose-6-phosphate dehydrogenase [1] |
Glucoside [2] |
Glucosides [2] |
Glycine [1] |
Glycolysis [1] |
glycolysis [1] |
Glycoside [1] |
glycosyltransferase inhibitor [1] |
Gold nanoparticles [1] |
Growth factors [1] |
Growth Hormone [1] |
guanine deaminase [1] |
guanine deaminase inhibitor [1] |
Guanine Quadruplex [1] |
gyrase inhibitor [1] |
H2L 7905958 [1] |
H37Rv [1] |
Ha 155 [1] |
HA-MRSA [1] |
HAART [2] |
HAART. [1] |
HDAC [1] |
Health Disparity [1] |
Hedgehog [1] |
Hedgehog pathway [1] |
Hedgehog Signaling [1] |
helminthiasis [1] |
helminths [1] |
Hemin [1] |
Hep G2 cell lines [1] |
Hep G2 Cells [1] |
heparin lyase [1] |
Hepatocyte Nuclear Factor 3Beta [1] |
hepatoprotective activity [1] |
HER2 Overexpression [1] |
HER2 positive breast cancer [1] |
herbal medicine [1] |
Hermes Antigen [1] |
Heterocycles [4] |
Heterocyclic [1] |
heterocyclic [1] |
heterocyclic compound [2] |
Heterocyclic compounds [2] |
heterocyclic compounds [1] |
Heterocyclic systems [1] |
HIF-1? [1] |
HIF-1? inhibitor [1] |
High Performance Liquid Chromatography [1] |
Hispanic [1] |
Histone deacetylase [1] |
Histone deacetylases [1] |
Histone H3 [1] |
HIV [3] |
Homogenous Dispersions [1] |
Homology modelling [1] |
Hormone-dependent breast cancer [1] |
HPLC [1] |
HSP90 [1] |
Hsp90 [1] |
Human [13] |
human [5] |
Human Cell [2] |
Human thymidylate synthase [1] |
Humans [10] |
Hydrodistillation [1] |
Hydrogen Bond [1] |
hydrogen bond [1] |
Hydrogen Catalyst [1] |
hydrolase inhibitor [1] |
hydrophobic [1] |
Hydroxychloroquine [1] |
Hydroxycolecalciferol Asian [1] |
hypoxanthine phosphoribosyltransferase [1] |
hypoxanthine phosphoribosyltransferase inhibitor [1] |
Hyssopus officinalis [2] |
Ibufenac [1] |
IC50 [2] |
Ic50 [1] |
IGF-1R [1] |
IGF-1R inhibitors [1] |
Image Analysis [1] |
Imidazo[1,2-a]quinoxaline [1] |
imidazo[1,2-a]quinoxaline [1] |
Imidazole [1] |
Imidazotriazine [1] |
Imine [1] |
Imine pyrazolopyrimidinone [1] |
Imine/amide-imidazole [1] |
immunoblotting [1] |
Immunology [1] |
in silico [1] |
In silico studies [1] |
in silico studies [1] |
in vitro [1] |
in vitro and cell lines [1] |
In Vitro Study [2] |
In vitro study [2] |
in vivo [1] |
in vivo pharmacokinetics [1] |
In-silico [5] |
In-silico activity [1] |
in-silico; phytoestrogens [1] |
In-vitro [2] |
Indazole [1] |
indazole [1] |
India [1] |
Indian [1] |
Indole [3] |
indole [4] |
Indole derivatives [1] |
Indole synthesis [1] |
Indole-benzimidazole hybrids [1] |
Indolealkylamine [1] |
Indolines [1] |
Induced fit [1] |
induced fit [1] |
Inductively Coupled Plasma Mass Spectrometry [1] |
infection [1] |
Inflammation [2] |
inflammatory [1] |
Inhibition [1] |
Inhibitor [1] |
inhibitor [1] |
Inhibitors [1] |
inhibitors [1] |
Inhibitory dose [1] |
Insect Repellent [1] |
Insect Repellents [1] |
Insecticide [1] |
insulin growth factor receptor 1 inhibitor [1] |
Insulin level [1] |
Insulin Resistance [1] |
Insulin resistance [2] |
Insulin. [1] |
interleukin 1 receptor associated kinase 4 [1] |
Interleukin-6 [2] |
Internalization [1] |
Interventions [1] |
In�vitro activity [1] |
Ion [1] |
ipilimumab [1] |
Iproniazid [1] |
IR [1] |
isatin [1] |
Isolation [2] |
isolation [1] |
Isolation And Purification [2] |
Isoprotein [2] |
Isoquinoline [1] |
Isoxazole [2] |
Isoxicam [1] |
Ivl Gene [1] |
Jackfruit Seed Starch [1] |
JAK/STAT3 [1] |
Juniperus macropoda [1] |
K ras protein [1] |
Kappa opioid receptor [1] |
Kaurane Derivative [2] |
Killer cells [1] |
Kinase inhibitors [1] |
kinase inhibitors [1] |
Kinetics [1] |
Knoevenagel condensation [2] |
kz 001 [1] |
kz 02 [1] |
LA-MRSA [1] |
Larva [1] |
Larvicidal [1] |
Larvicidal activity [2] |
Larvicidal activity. [2] |
Leaching [1] |
Legionella pneumophila [1] |
Leptin [1] |
lethargy [1] |
leukemia [1] |
lexibulin [1] |
life cycle [1] |
ligand [1] |
ligand binding [1] |
Lignans [1] |
Lipid profile [1] |
lipophilicity [1] |
Liposome [1] |
Liver Cancer [1] |
liver cell carcinoma [1] |
liver diseases [1] |
Lumiracoxib [1] |
lump [1] |
Lung cancer [2] |
lung cancer [2] |
lysogenic [1] |
Lysophosphatidic Acid Receptor [1] |
lytic [1] |
M. tuberculosis [1] |
Machine learning [1] |
Macrogol [2] |
macromolecule [1] |
Macrophage [1] |
Macrophages [1] |
Major Clinical Study [1] |
Malaria [1] |
Malignancy [1] |
malignant neoplasm [2] |
Mammals [1] |
mandelic acid [1] |
MAO inhibitors [3] |
MAPK [1] |
Mass Fragmentography [1] |
MCF cell lines [1] |
MCL-1 [1] |
MD simulation [1] |
MDM2-p53 inhibitor [1] |
MDR [3] |
Mechanism [2] |
Mechanism of action [2] |
mechanism of action [2] |
Mechanisms [1] |
Medical Nanotechnology [1] |
Medicinal chemistry [1] |
medicinal chemistry [3] |
medicinal plants [1] |
Medicinal properties [1] |
MEK [1] |
Melanoma [1] |
melanoma [1] |
Melphalan [1] |
Membrane damage [1] |
membrane protein [1] |
Membrane Proteins [1] |
Mental Disease [1] |
Mepacrine [1] |
mercaptopurine [1] |
metabolic disorder [1] |
Metabolism [4] |
metabolism [2] |
Metabotropic Receptor 5 [1] |
metal complexes [1] |
Metal forming nanoparticles [1] |
Metal Nanop s [1] |
metal-free synthesis [1] |
MetAP-2 [1] |
metastatic melanoma [1] |
metastatic uveal melanoma [1] |
Methanol [1] |
method of preparation [1] |
Mice [1] |
Michael reaction [1] |
Microbes [1] |
Microbial Sensitivity Test [1] |
Microglia [1] |
Microrna [1] |
Microscop [1] |
microsomal stability [1] |
Microsponge [1] |
microsponge delivery system [1] |
Microtubule [1] |
Microwave heating [3] |
Minocycline [1] |
mirdametinib [1] |
miscellaneous drugs and agents [1] |
Mitochondria-dependent cell death [1] |
Mitochondrial membrane permeability [1] |
mitochondrial pathway [1] |
Mitochondrion [2] |
mitogen activated protein kinase kinase 1 [1] |
mitogen activated protein kinase kinase 2 [1] |
mitogen activated protein kinase kinase inhibitor [1] |
MLR [1] |
MOA [1] |
Models, Biological [1] |
Molecular Docking [2] |
Molecular docking [9] |
molecular docking [8] |
molecular docking studies [1] |
molecular dynamic simulation [1] |
molecular dynamic simulations [1] |
Molecular Dynamics [2] |
Molecular dynamics [1] |
molecular dynamics [3] |
molecular dynamics simulation [1] |
Molecular dynamics simulations [2] |
molecular dynamics simulations [1] |
molecular dynamics studies [1] |
molecular hybridization [1] |
Molecular Model [1] |
Molecular modeling [5] |
Molecular modelling [4] |
Molecular similarity [1] |
molecular simulation [1] |
Molecular simulations [1] |
Molecular Structure [1] |
molecular weight [1] |
Molecularly Targe [1] |
Molecules [1] |
Monoamine Oxidase [1] |
monoamine oxidase [2] |
Monoamine Oxidase Inhibitor [1] |
Monoamine Oxidase Inhibitors [1] |
monoamineoxidase [1] |
Monoclonal Antibody [2] |
monoclonal antibody [1] |
Monoterpenes [1] |
Mouth Carcinoma [1] |
MRSA [2] |
mTOR pathways [1] |
MTT assay [3] |
Mtt Assay [1] |
Mu opioid receptors [1] |
Mulberry [1] |
multi-drug resistance [1] |
multi-target directed ligands [2] |
Multicomponent Reactions [1] |
Multicomponent reactions [1] |
multicomponent reactions [2] |
multidrug resistance [1] |
Multidrug resistance. [1] |
multidrug resistance. [1] |
Multitarget [1] |
Murine double minute 2 (MDM2) [1] |
Mutagenicity [1] |
Mutant EGFR inhibitors [1] |
mutation [1] |
Mutational analysis [1] |
Mycobacterium tuberculosis [1] |
n [2 [(4 hydroxyphenyl)amino] 3 pyridinyl] 4 methoxybenzenesulfonamide [1] |
Naltrexone [1] |
Nano drug delivery [1] |
nano-medicine [1] |
Nanocatalysis [1] |
nanoformulations [1] |
Nanomedical sector [1] |
Nanomedicine [1] |
Nanoparticle (Nps) [1] |
Nanoparticles [3] |
nanosensor [1] |
Nanotoxicology [1] |
Naringenin [1] |
Natural polymers [1] |
Natural products [6] |
natural products [1] |
Naturally occurring fused pyrimidines [1] |
nausea [1] |
NCI [1] |
necrosis [1] |
Neoplasm [2] |
neoplasm [3] |
Neoplasms [3] |
Nepeta cataria [1] |
Nerve Cell Adhesion Molecule L1 [1] |
Nervous System Diseases [1] |
Network model [1] |
neurofibroma [1] |
neurologic disease [1] |
Neurological disorders [1] |
Neuropathic pain [1] |
Neuroprotective agents [1] |
neuroprotective agents [1] |
Neurotransmitters [1] |
New anti-inflammatory chemotypes [1] |
Nf Kappa B Pathway [1] |
NF-?B [1] |
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 1 [1] |
nimodipine [1] |
Niperotidine [1] |
nitrogen-containing heterocyclic [1] |
nivolumab [1] |
NNRTI [1] |
Nociceptin [1] |
Non human [1] |
Non Insulin Dependent Diabetes Mellitus [1] |
non small cell lung cancer [1] |
Non-covalent EGFR inhibitors [1] |
Non-purine based compounds [1] |
Non-selective [1] |
Nonh [1] |
Nonhuman [1] |
nonhuman [4] |
Notch pathway [1] |
Notch Receptor [1] |
Notch1 Receptor [1] |
novel drug delivery system [1] |
Novel drug delivery systems [1] |
novel species [1] |
NRTI [1] |
Nsc 48300 [1] |
NSCLC [2] |
Nsp15 [1] |
Nuclear factor-kappa-B [1] |
Nuclear localization [1] |
Nucleosides [1] |
nutlin [1] |
nutraceutical [2] |
nutrition supplement [1] |
Nyasol [1] |
Nyctanthes arbor-tristis [1] |
Obesity [1] |
Oestradiol [1] |
Oestrogen receptors [1] |
OGTT [1] |
Oils, Volatile [1] |
Oligomycin [1] |
ombrabulin [1] |
Oncogene Proteins [1] |
oncoprotein [1] |
ophthalmology [1] |
Opioid [2] |
Oral Absorption [1] |
Oral delivery [1] |
Organic Chemicals [1] |
organic compound [1] |
Organic synthesis [1] |
organocatalysis [2] |
Organochlorines [1] |
Organophosphorus pesticides [1] |
ORL-1 [1] |
Orserdu [2] |
Osteopontin [1] |
Oxazole [1] |
oxazoline [1] |
Oxepinopyrimidines [1] |
Oxidation Reduction Reaction [1] |
Oxidative stress [2] |
Oxyphenbutazone [1] |
Oxyphenisatine [1] |
P Size [1] |
P-coumaric acid [1] |
P-gp [1] |
P53 [1] |
p53 [2] |
Pan PPAR ligands [1] |
pancreas adenocarcinoma [1] |
pancreas cancer [1] |
pancreas metastasis [1] |
PAPYRUS [1] |
Parkinson's disease [1] |
Parkinson’s disease [1] |
Parkinson�s disease [1] |
PARP [1] |
PARP-1 [2] |
PARP-1 inhibitors [1] |
Partial agonist [1] |
particulate matter [1] |
Patients [1] |
PD [1] |
PDE5 [1] |
pembrolizumab [1] |
pentostatin [1] |
Peptide nucleic acids [1] |
Peptide synthesis [1] |
Peptides [1] |
peptides [1] |
Perforins [1] |
peripheral edema [1] |
Peroxisome proliferator-activated receptor [1] |
Pesticides [1] |
Pf 8380 [1] |
phage [1] |
Phagocytosis [1] |
Pharmaceutical Industry [2] |
Pharmaceutical therapy [1] |
Pharmacodynamics [2] |
pharmacodynamics [1] |
Pharmacogenetics [2] |
pharmacokinetic properties [1] |
Pharmacokinetics [2] |
pharmacokinetics [1] |
Pharmacological activities [3] |
Pharmacological activity [1] |
pharmacological activity [1] |
Pharmacophore [2] |
pharmacophore [3] |
Pharmacophore mapping [1] |
pharmacophore mapping [1] |
pharmacophore model [1] |
Pharmacovigilance [1] |
Phase 1 Clinical Trial (Topic) [1] |
Phase 2 Clinical Trial (Topic) [1] |
Phase 3 Clinical Trial (Topic) [1] |
Phenol [1] |
phenol derivative [1] |
Phenylenediamine derivative [2] |
Phosphate [1] |
Phosphodiesterase [1] |
phosphoric acid [1] |
phosphorus [1] |
Phosphotransferase [2] |
Phosphotransferase Inhibitor [1] |
photodynamic [1] |
Photoprotective activity [1] |
photoprotective activity [1] |
Photoreception [1] |
Phylogeography [1] |
Physical and chemical processes [1] |
Physico-chemical characterization [1] |
physicochemical properties [1] |
Physicochemical property [1] |
Physicochemical techniques [1] |
Physiological Functions [1] |
Physiological Models [1] |
Physiology [2] |
Phytochemical [1] |
phytochemical [1] |
Phytochemicals [3] |
Phytoestrogens [1] |
Phytoestrogens (PEs) [1] |
Phytotherapy [2] |
PI3K [1] |
PI3K/AKT pathway [1] |
Pictet-spengler reaction [1] |
Pictet-spenglerase enzymes [1] |
pictilisib [1] |
PIK3CA [1] |
pimasertib [1] |
Piper attenuatum [1] |
Piper species [1] |
Piperazine [1] |
Pirprofen [1] |
PK [1] |
PKM2 inhibitors [1] |
Plant [1] |
Plant Extract [2] |
Plant extract [1] |
Plant Extracts [1] |
Plant Medicinal Product [1] |
Plant Metabolities [1] |
Plant Oils [1] |
Plants [2] |
PLGA nanoparticles [1] |
PLGA-doxorubicin conjugate [1] |
plinabulin [1] |
pMIC [1] |
PNA/DNA duplex [1] |
PNAs [1] |
Podophyllotoxin [1] |
point-of-care test [1] |
Point-of-care testing [1] |
Poloxamer [1] |
Polyethylene Oxides [1] |
Polymers [1] |
Polymersomes [1] |
Polymer�drug conjugation [1] |
Polyol pathway [1] |
Polyphenols [2] |
polyphenols [1] |
Potentilla [1] |
Potentilla Atrosanguinea [1] |
Potentilla atrosanguinea [1] |
Potentilla fulgens [1] |
PPAR gamma [1] |
Preparation technique [1] |
Principal Component Analysis [1] |
Priority Journal [2] |
Proatropisomeric [1] |
Probes [1] |
Process Development [1] |
Process Optimization [1] |
Prodrug [1] |
prodrug [1] |
Prodrugs [1] |
production [1] |
Prolactin [1] |
proliferation [1] |
Prostate [1] |
Prostate cancer [1] |
Proteasome [1] |
proteasome [1] |
protein bcl xl [1] |
Protein Binding [1] |
protein binding [1] |
protein c jun [1] |
protein degradation [1] |
protein domain [1] |
Protein Inhibitor [1] |
protein inhibitor [1] |
Protein Isoforms [1] |
Protein Kinase [2] |
Protein Kinase Inhibitor [1] |
Protein kinase inhibitor [1] |
protein kinase inhibitor [2] |
Protein Kinase Inhibitors [2] |
protein structure [1] |
Protein Tyrosine Kinase [1] |
protein tyrosine kinase inhibitor [1] |
Protein tyrosine phosphatase 1B [1] |
protein tyrosine phosphatase SHP 2 [1] |
Proteinase Inhibitor [1] |
Proteins [1] |
Proteolysis [1] |
proteolysis targeting chimera [2] |
proteosome [1] |
Pseudomonas Aeruginosa [1] |
Punjabi (People) [1] |
purine derivative [1] |
purine uti [1] |
pyran annulated heterocycles [1] |
Pyrazole [2] |
Pyrazole Derivative [1] |
Pyrazoles [2] |
pyrazolines [1] |
pyrazolo [3,4] pyrimid [1] |
Pyrazolo[1,5-c]quinazolines [2] |
Pyrazolo[1,5-c]quinazolines and their derivatives [2] |
Pyrazolo[3,4-d]pyrimidine [1] |
Pyridine [1] |
pyridine [1] |
Pyrimidine [1] |
pyrimidine [2] |
pyrimidines [2] |
Pyrimidinone derivative [1] |
Pyrimidoazepines [1] |
Pyrimidodiazepines [1] |
pyruvate kinase [1] |
pyruvate kinase M2 [1] |
QSAR [1] |
Quality control [1] |
Quantitative Analysis [2] |
Quantitative Structure Activity R [1] |
Quantitative Structure Activity Relation [1] |
Quantum dot [1] |
quasi emulsion solvent diffusion [1] |
quinazoline [1] |
Quinazoline Derivative [1] |
Quinazolines [2] |
Quinazolinone [1] |
quinolin-2(H)-one [1] |
quinolin-4(H)-one [1] |
Quinoline [2] |
Quinolines [2] |
quinolone [1] |
R. tuberosa [1] |
Racemosides [1] |
Radiation Exposure [1] |
Radical [1] |
radicicol [1] |
Radioactivity [1] |
Radiosensitivity [1] |
RAF [1] |
RAS [1] |
rash [1] |
ravoxertinib [1] |
rdea 119 [1] |
RdRp [1] |
Reaction Analysis [1] |
Reaction mechanism [1] |
Reactive Oxygen Metabolite [1] |
Reactive oxygen metabolite [1] |
Reactive oxygen species [1] |
Rebaudioside A [1] |
rebaudioside A [2] |
Receptor [1] |
Receptors [1] |
Receptors, G-Protein-Coupled [2] |
Redox Effector Factor 1 [1] |
Redox reaction [1] |
Redox sensor [1] |
redox-active [1] |
Reductive cyclization [1] |
refametinib [1] |
Regulation [1] |
Regulatory Authorities [1] |
Regulatory guidelines [1] |
Regulatory toxicology [1] |
remdesivir [1] |
Repurposed drugs [1] |
Resistance [6] |
resistance [1] |
respiratory tract agent [1] |
respiratory tract disease [1] |
Resveratrol [1] |
Retinoic Acid [1] |
reversible MAO inhibitors [2] |
Revertant [1] |
Review [8] |
rhodanine [1] |
RIN analysis [1] |
room temperature [1] |
Rosmarinus officinalis [1] |
RT [1] |
RT-PCR [2] |
Rutoside [1] |
S. rebaudiana [2] |
Saffron [1] |
Salmonella enterica serovar Typhimurium [1] |
Salmonella typhimurium [1] |
SAR [11] |
SARS-CoV-2 [6] |
Scavenger Receptor [1] |
SCLC [2] |
Second generation [1] |
secondary metabolites [1] |
Selective estrogen receptor degraders (SERDs) [1] |
Selective estrogen receptor modulators [1] |
Selectivity [1] |
selumetinib [1] |
Semi-synthetic [1] |
SERD [1] |
Serendipity [1] |
SERM [1] |
SERMs [1] |
Sesquiterpenes [1] |
Seven-membered ring fused pyrimidines [1] |
SGs [1] |
Shankhpushpi [1] |
Shatavarins [1] |
Shikonin derivatives [1] |
side effect [1] |
Signal Tr [1] |
Signal Transduction [1] |
Signal transduction [1] |
signal transduction [1] |
Signalling [1] |
Signalling pathways [2] |
signalling pathways [1] |
Silver Nanop [1] |
Simulation studies [1] |
Single hit [1] |
Single Nucleotide Polymorphism [1] |
Six-membered ring fused pyrimidines [1] |
Skimmia laureola [1] |
Sodium azide [2] |
Sodium dodecyl sulphate [1] |
solid tumor [1] |
Solubility [1] |
solubility [1] |
solvent injection [1] |
Somatomedin C [1] |
somatomedin C receptor [1] |
Sonic Hedgehog Protein [1] |
Sonidegib [1] |
sorafenib [1] |
Specific antigen [1] |
spectroscopy [1] |
Spectrosocopy [1] |
Spiropyrans [1] |
Sponges [1] |
SSBs [1] |
Stable Dispersions [1] |
Staphylococcus Aureus [1] |
Staphylococcus aureus [2] |
STAT3 protein [1] |
Static Electricity [1] |
Status epilepticus [1] |
Stereochemistry [1] |
Steric Hindrances [1] |
Steroid [1] |
Steroid sulfatase [1] |
steroid sulphatase [1] |
Steroidal alkaloids [1] |
Stevia [2] |
Stevia Rebaudiana [1] |
Stevia rebaudiana [2] |
Steviol [1] |
Steviol glycosides [1] |
Stevioside [2] |
Structure Activity Relation [3] |
structure activity relation [1] |
Structure Analysis [1] |
Structure-Activity Relationship [2] |
Structure-activity relationship [1] |
structure-activity relationship [2] |
Structure-activity Relationship. [1] |
structure-based virtual screening [1] |
Sudoxicam [1] |
sulfur [1] |
Sulfur compounds [1] |
Sulindac [1] |
Sulphatase inhibitors [1] |
Sulphonamides [1] |
Surface Active Agents [1] |
Surfactant [2] |
Surfactant-Assisted Dispersion [1] |
Survival Rate [1] |
sustainable developments [2] |
Sustainable release [1] |
Sweetening Agent [2] |
Sweetening Agents [2] |
Synergism [1] |
Synergism. [1] |
Synthesis [19] |
synthesis [2] |
Synthesis (chemical) [1] |
Synthesis Molecular modeling [1] |
SynthesisAryl aldehydes [1] |
Synthetic strategies [1] |
tamoxifen [1] |
tannins [1] |
Targeting [1] |
Targeting. [1] |
Targets [3] |
Taste [2] |
Taste Receptors, Type 1 [1] |
Taste Receptors, Type 2 [1] |
Telomerase [1] |
Terpene [2] |
Terpene Derivative [1] |
Terpenes [1] |
terpenoids [2] |
Tetrahydro-?-carbolines [1] |
Tetrahydrobenzo[b]pyrans [1] |
Tetrahydroimidazopyridines [1] |
Tetrahydroisoquinoline [1] |
tetramer [1] |
tetramerization [1] |
Tetrazole [1] |
Theaflavin 3,3' Digallate [1] |
therapy resistance [1] |
Thiadiazepines [1] |
Thiazole [1] |
Thiazoles [1] |
Thiazolidinedione [1] |
thiazolidinedione [1] |
thieno[2 [1] |
Thiepinopyrimidines [1] |
thin-film rehydration [1] |
Thio-ether linkage [1] |
Thy 1 Antigen [1] |
Thymidylate synthase [1] |
thyroid hormone [1] |
thyroid hormone-binding proteins [1] |
Thyroid Hormones [1] |
Tienilic Acid [1] |
Tolcapone [1] |
Tolrestat [1] |
Topoisomerase [3] |
Topoisomerase inhibition [1] |
Topoisomerase inhibitors [3] |
Topoisomerases [1] |
Toxicity [3] |
Traditional uses [1] |
trametinib [1] |
transcription factor [1] |
Transcription Factor Nfat [1] |
Transcription Factors [1] |
Translational Research [1] |
translational research [2] |
Trastuzumab [1] |
trastuzumab emtansine [1] |
Trastuzumab. [1] |
Trialkylphosphite [1] |
triple-negative breast cancers [1] |
trisodium citrate dihydrate [1] |
Troglitazone [1] |
Trovafloxacin [1] |
tuberculosis [1] |
Tubulin [3] |
tubulin [2] |
Tubulin Modulators [1] |
Tubulin polymerization inhibitors [1] |
Tumor [1] |
Tumor Necrosis Factor Alpha [1] |
tumour microenvironment [1] |
Type 2 diabetes mellitus [1] |
Tyrosine kinase [2] |
Tyrosine Kinases [1] |
ubiquitin [1] |
ubiquitin protein ligase [1] |
Ubiquitin-Protein Ligases [1] |
Unclassified Drug [2] |
Unclassified drug [3] |
unclassified drug [1] |
unclassified drug binding site [1] |
Unindexed Drug [1] |
United States [1] |
United States Food and Drug Administration [1] |
uprosertib [1] |
urml 3881 [1] |
US FDA approved Fused pyrimidines [1] |
Vaccines [1] |
vaccines [1] |
Vantictumab [1] |
variants [1] |
Vascular Targeting Agent [2] |
Vegetable Oil [1] |
VEGFR-2 [1] |
vemurafenib [1] |
venetoclax [1] |
verubulin [1] |
vibrating orifice aerosol generator [1] |
vinblastine [1] |
Vinca Alkaloid [1] |
vincane [1] |
vincristine [1] |
Vinpocetine [1] |
Virtual screening [1] |
virtual screening [2] |
Vismodegib [1] |
Voglibose [1] |
vomiting [1] |
Water [1] |
Water controlled study [1] |
Western blotting [3] |
Wnt Pathway [1] |
Wnt Protein [1] |
wx 554 [1] |
X Ray Crystallography [1] |
X-ray fluorescence [1] |
X-ray fluorescence imaging research projects [1] |
Xanthine oxidase [2] |
Xanthine oxidase inhibitory activity [1] |
xenograft mice model [1] |
Ximelagatran [1] |
YP2C19*2 [1] |
Zeta Potential [1] |
Zomepirac [1] |
α-amylase [1] |
β-Cells [1] |